LIQUID COLOR MEDICAL BLUE 485-33157-1

such as packaging, medical devices and personal care products.  

Mevopur™ Healthcare Colorants and Formulations: a range of medical grade concentrates and pre-colored formulations for a wide range of polymers used in applications such as remote patient monitoring, circulating blood contact, and invasive devices, with pre-tested biocompatibility according to ISO 10993, change control in place, production certified to ISO 13485-2016 and DMF/MAF files available

Materials or feedstock substitution Product design or reformulation Equipment or process modifications Spill or leak prevention On­site reuse, recycling or recovery Improved inventory management or purchasing techniques Good operator practice or training About us News Contact us Stay connected HEALTH healthycanadians.gc.ca TRAVEL travel.gc.ca SERVICE CANADA servicecanada.gc.ca JOBS jobbank.gc.ca ECONOMY actionplan.gc.ca Canada.gc.ca Terms and Conditions Transparency Version: 3.13.0 Identify at least one reason why no option to reduce the use or creation of this substance was implemented at your facility: Select the applicable reason or reasons ** There are no alternative processes and/or equipment identified, New equipment and/or processes were investigated, however, deemed unfeasible Explanation of the reasons why no option will be implemented   Rationale for why the listed options were chosen for implementation   General description of any actions undertaken by the owner and operator of the facility to reduce the use and creation of the toxic substance at the facility that are outside of the plan   License Number of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this substance (format TSRPXXXX): * TSRP0123 Name of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this substance (First Name Last Name) Daryl Chartrand License Number of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (format TSRPXXXX): * TSRP0123 Name of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (First Name Last Name) Daryl Chartrand What version of the plan is this summary based on?

Safety & Health Indemnity. Buyer acknowledges that Seller has furnished to Buyer Material Safety Data sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

Operating Income $3,783 $4,300 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Previous Guidance Current Guidance $3,783 $4,650 $308 $410 $308 $430 $1.93 $2.80 $1.93 $3.00 (1) (1)(1) (1)(1) (1) $442 $457 $580 $1.74 $1.93 $3.00 FULL YEAR 2019 – 2021 ORGANIC GROWTH 16 Sales Adjusted EBITDA $3,981 $3,783 $4,650 + 17% (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1)(1) + 31% + 72% ($ in millions) 2021E Adjusted EBITDA 580$ Free Cash Flow 280$ Total Debt 1,860 Less: Cash (755) Net Debt 1,105$ 2021E Net Debt / Adjusted EBITDA 1.9x 17 BALANCE SHEET • Acquisition of Magna Colours completed on July 1 – expands sustainable solutions portfolio through water-based inks technology • Deleveraging to 1.9x net debt to adjusted EBITDA by the end of 2021 • Driven by record adjusted EBITDA performance and strong free cash flow generation from asset light business • Future cash deployment: M&A, opportunistic share repurchases and balance sheet / continued leverage reduction 3.5x 2.7x 1.9x Net Debt / Adjusted EBITDA (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition SUSTAINABILITY FOR A BETTER TOMORROW • Revenue from sustainable solutions expected to grow 14% in 2021 as our innovation efforts and collaboration with customers continues to accelerate • Investments centered around innovation and global sustainability megatrends o Enabling a circular economy – Technologies that allow for increased use of post-consumer recycled (PCR) material and improve recyclability of plastics o Light-weighting – Composites and CAI applications to reduce weight and material requirements, which minimize energy and carbon emissions o Eco-Conscious – Health and human safety applications as well as Avient’s alternative materials to replace lead, PVC, halogens, BPA and other less eco-friendly options 2016 2017 2018 2019 2020PF** Bio-polymers Reduced Energy Use Human Health & Safety Sustainable Infrastructure VOC Reduction Recycle Solutions Eco-Conscious Lightweighting Revenue From Sustainable Solutions* 2016-2020 $405M $455M *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Masterbatch business $340M $550M $790M 19 Key Updates • Includes Clariant Masterbatch performance • Increases disclosures and ESG data • Provides performance updates on 2030 Sustainability Goals • Commits to operational carbon neutrality in 2050 and 100% renewable energy by 2050 (RE 100) • Announces Avient’s participation in U.N.

Avient reserves the right to verify the changed sub-tier supplier structure. 5.0 Avient Business Expectations Suppliers may be asked to provide additional material specific documentation related to the following functional areas:  Environmental, Health, and Safety  Regulatory  Sourcing  Purchasing  Technology / Research & Development Any other functional group-specific requirements may be communicated through the appropriate Avient representative.

The U.S. federal Occupational Safety and Health Administration (OSHA) has implemented its plan to align its Hazard Communication Standard (HCS) with the GHS framework.